Terms: = Uterine cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Treatment
26 results:
1. An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical cancer.
Lukovic J; Pintilie M; Han K; Fyles AW; Bruce JP; Quevedo R; Pugh TJ; Fjeldbo CS; Lyng H; Milosevic MF
Clin Cancer Res; 2024 Mar; 30(6):1200-1207. PubMed ID: 38180733
[TBL] [Abstract] [Full Text] [Related]
2. The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial cancer.
Dobroch J; Bojczuk K; Kołakowski A; Baczewska M; Knapp P
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408440
[TBL] [Abstract] [Full Text] [Related]
3. The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
Xu L; Li C; Hua F; Liu X
Med Oncol; 2021 Apr; 38(5):58. PubMed ID: 33847822
[TBL] [Abstract] [Full Text] [Related]
4. The Oral cxcr4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in Cervical cancer Treated With Radiation Therapy and Concurrent Chemotherapy.
Chaudary N; Hill RP; Stulik L; Milosevic M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1317-1324. PubMed ID: 33771702
[TBL] [Abstract] [Full Text] [Related]
5. Targeting CXCL12/cxcr4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
Lecavalier-Barsoum M; Chaudary N; Han K; Pintilie M; Hill RP; Milosevic M
Br J Cancer; 2019 Jul; 121(3):249-256. PubMed ID: 31239542
[TBL] [Abstract] [Full Text] [Related]
6. CXCL12 modulates the radiosensitivity of cervical cancer by regulating CD44.
Fu Z; Zhang P; Luo H; Huang H; Wang F
Mol Med Rep; 2018 Dec; 18(6):5101-5108. PubMed ID: 30320394
[TBL] [Abstract] [Full Text] [Related]
7. Targeting the CXCL12/cxcr4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
[TBL] [Abstract] [Full Text] [Related]
8. O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical cancer Cells via Upregulation of cxcr4 Expression.
Ali A; Kim SH; Kim MJ; Choi MY; Kang SS; Cho GJ; Kim YS; Choi JY; Choi WS
Mol Cells; 2017 Jul; 40(7):476-484. PubMed ID: 28681591
[TBL] [Abstract] [Full Text] [Related]
9. The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells.
Gu HQ; Zhang ZB; Zhang JW; Wang QQ; Xi XW; He YY
Arch Gynecol Obstet; 2017 Apr; 295(4):987-995. PubMed ID: 28239742
[TBL] [Abstract] [Full Text] [Related]
10. CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study.
Yadav SS; Prasad SB; Prasad CB; Pandey LK; Pradhan S; Singh S; Narayan G
Clin Exp Metastasis; 2016 Jun; 33(5):431-9. PubMed ID: 26970955
[TBL] [Abstract] [Full Text] [Related]
11. cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/cxcr4 axis.
Teng F; Tian WY; Wang YM; Zhang YF; Guo F; Zhao J; Gao C; Xue FX
J Hematol Oncol; 2016 Feb; 9():8. PubMed ID: 26851944
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of cxcr4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract] [Full Text] [Related]
13. MET receptor is a potential therapeutic target in high grade cervical cancer.
Miekus K; Pawlowska M; Sekuła M; Drabik G; Madeja Z; Adamek D; Majka M
Oncotarget; 2015 Apr; 6(12):10086-101. PubMed ID: 25888626
[TBL] [Abstract] [Full Text] [Related]
14. Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of cxcr4 chemokine receptor expression.
Kim B; Park B
Biochemistry; 2014 Dec; 53(48):7562-9. PubMed ID: 25407882
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic silencing of cxcr4 promotes loss of cell adhesion in cervical cancer.
Yadav SS; Prasad SB; Das M; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Biomed Res Int; 2014; 2014():581403. PubMed ID: 25114911
[TBL] [Abstract] [Full Text] [Related]
16. Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro.
Wen WW; Xie S; Xin XL; Geng MY; Ding J; Chen Y
Acta Pharmacol Sin; 2013 Dec; 34(12):1554-9. PubMed ID: 24141568
[TBL] [Abstract] [Full Text] [Related]
17. Hypoxia and metastasis in an orthotopic cervix cancer xenograft model.
Chaudary N; Mujcic H; Wouters BG; Hill RP
Radiother Oncol; 2013 Sep; 108(3):506-10. PubMed ID: 23856487
[TBL] [Abstract] [Full Text] [Related]
18. [Expression of Id1 and Id3 in endometrial carcinoma and their roles in regulating biological behaviors of endometrial carcinoma cells in vitro].
Sun L; Li X; Liu G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):812-8. PubMed ID: 23803189
[TBL] [Abstract] [Full Text] [Related]
19. Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.
Felix AS; Stone RA; Chivukula M; Bowser R; Parwani AV; Linkov F; Edwards RP; Weissfeld JL
Int J Cancer; 2012 Jul; 131(2):E114-21. PubMed ID: 22025313
[TBL] [Abstract] [Full Text] [Related]
20. Silencing of cxcr4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.
Wang J; Cai J; Han F; Yang C; Tong Q; Cao T; Wu L; Wang Z
Int J Gynecol Cancer; 2011 Aug; 21(6):981-7. PubMed ID: 21738044
[TBL] [Abstract] [Full Text] [Related]
[Next]
